Facebook
Twitter
LinkedIn
ForwardClick here to search courses using NAPNAP's previous Course Catalog layout.
Title
Category
Credits
Event date
Cost
- Primary Care
- 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. Due to COVID-19, children are entering the welfare system with a higher level of needs and there are fewer foster homes available. Consequently, placement availability and stability have reached a critical state and larger numbers of children in the welfare system are without placements leading to situations where children are sleeping in CPS offices and hotel rooms. The NP is a gatekeeper for the children and families involved in the welfare system. This presentation will provide practical applications that NPs can implement in their practices to support placement stability and improve the life of the child in foster care.
- Primary Care
- 0.50 Contact hours
$10.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $5 for NAPNAP Members. For non- members, this continuing education activity rate is $10. Blunt abdominal trauma constitutes more than 80% of abdominal traumas in childhood. The 2019 Journal of Pediatric Surgery Evidence-based Practice systematic review of the non-operative management of solid organ injuries advises it may be safe to send children with solid organ injuries home sooner with less intervention and supports outpatient management with primary care providers. The management of solid organ injuries has been evolving over the last 10 years and understanding these new Pediatric Surgical Association’s guidelines have implications for advanced practice providers in both primary and acute care settings. The lecture will review the epidemiology of pediatric solid organ injury, the indications for non-operative management and will focus on the recommendations which outpatient pediatric-focused NPs can use to advise families on activity, follow-up and need for emergent re-assessment.
- Primary Care
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which contains 0.25 pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Diabetes is a chronic condition that requires intensive medical and psychological management with rapidly rising prevalence in the U.S. The most common form of pediatric diabetes is type 1 diabetes, affecting 1.25 million children who are two to four times more likely to have other autoimmune conditions including Hashimoto's thyroiditis, celiac disease and adrenal insufficiency than the general population. Timely screenings as recommended by the American Diabetes Association and proper assessment is key to identifying comorbidities and preventing both diabetes related complications as well as treating associated endocrine pathologies including those that can be potentially life threatening. This case-based, interactive presentation will provide pediatric advanced practice providers with robust clinical pearls on recognizing and managing endocrine disorders commonly seen in patients with diabetes mellitus, type 1.
- Primary Care
- Controlled Substances CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which contains 1.00 pharmacology, 1.00 Controlled Substances and 0.25 Psychopharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. The American Academy of Pediatrics recommends medication assisted treatment for adolescents with opioid use disorders (MOUD) but less than 12% of affected youth ever receive treatment and even fewer receive MOUD. In an effort to get evidence-based treatment to people with OUD, in 2021 the HHS relaxed the laws that govern MOUD prescribing. Similar to collaborative care approaches to treatment of other mental health disorders, pediatric-focused NPs should be the first person their patients look to for helping them recover from OUDs. This case-based presentation will give participants an overview of screening and evidence-based treatment for youth with OUDs, followed by practical advice and resources for preparing a practice to care for this population.
- Primary Care
- Mental Health
- 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour. This continuing education activity is offered at discounted rate of $12.50 to NAPNAP Members. For non- members, this continuing education activity rate is $25. Social justice issues and COVID-19 have exposed inequities to accessing high-quality care throughout the health care system. “This Moment in Time” presents an opportunity to leverage our outrage and take steps to make sustainable changes that promote equitable care across all populations. This presentation focuses on the critical first step in the transformation to providing equitable and inclusive care to our youth. Using a framework to recognize implicit bias, videos and cases will be critiqued to manage implicit bias with BIPOC, LGBTQIA+ and disabled youth.
- Primary Care
- 1.00 Contact hours
$20.00
1.0 NAPNAP contact hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. For members this continuing education activity rate is $10. For non-members, this continuing education activity rate is $20. This presentation will provide an overview of two of the most common neurocutaneous disorders, tuberous sclerosis complex (TSC) and neurofibromatosis type 1 (NF1). We will discuss assessment features, diagnostic testing and criteria/screening tools, benefits and limitations of genetic testing, and recommendations for ongoing surveillance and management.
- Primary Care
- 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which contains 0.25 pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non- members, this continuing education activity rate is $25. Alarmed about increasing numbers of young people contemplating or attempting suicide? Need to expand your knowledge of youth suicidality? This session will provide an overview of the epidemiology of youth suicide, and present evidenced-based approaches to preventing this tragic loss of young life. Related health equity and social determinant of health issues, including lethal means reduction will be discussed. The session will also introduce the Alliance to Prevent Youth Suicide, a new five year initiative supported by NAPNAP Partners for Vulnerable Youth. Attendees of this session will leave with increased knowledge, tools and resources to assist in addressing this critical issue.
- Primary Care
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which contains 0.25 pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This session will discuss the NAEPP Focused Update to the Asthma Management Guidelines. The presenter will discuss the use of single maintenance and reliever therapy (SMART) for children and practice implications for nurse practitioners. The presentation will include case studies and encourage audience participation.
- Primary Care
- FREE for Members
- Pharmacology CE
- 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour, 1.0 pharmacology contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. Before 2018, there were no U.S. Food and Drug Administration approved medications for managing seizures in Dravet syndrome (DS). Common agents used in the antiepileptic drug regimens of patients with DS included clobazam, valproic acid, topiramate, and levetiracetam, among others; however, these agents alone rarely provide adequate seizure control. Management of seizures in DS changed in recent years with the approval of cannabidiol and stiripentol in 2018 and fenfluramine in 2020. This continuing education article summarizes available efficacy and safety data involving cannabidiol, stiripentol, and fenfluramine and provides a practical review of dosing strategies, pharmacokinetics, and monitoring interventions relevant to their use. J Pediatr Health Care. (2022)
36, 479−488
JPHC CE: Genital Examination of the Prepubertal Female: Essentials for Pediatric Nurse Practitioners
- Primary Care
- FREE for Members
- 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. The gynecologic assessment in prepubertal children is an essential element of a thorough physical examination. It is not unusual for pediatric health care providers, including pediatric nurse practitioners (PNPs), to feel challenged by assessing for gynecologic signs and symptoms and performing a physical examination of the external genitalia in prepubertal girls (Bhoopatkar, Wearn, & Vnuk, 2017; Dabson, Magin, Heading, & Pond, 2014; McBain, Pullon, Garrett, & Hoare, 2016). The benefits of routine genital examinations have been discussed in the literature, including increasing patient and caregiver comfort with an examination, improved health care provider skill and confidence with examination and diagnostic assessment, providing a baseline for future examinations, and documentation of previously undiscovered anomalies (Johnson, 2002). This continuing education article will discuss genital examination preparation and techniques, normal prepubertal hymenal variants, common prepubertal gynecologic problems, and genital examination findings concerning abuse. J Pediatr Health Care. (2022) 36, 489-499